Literature DB >> 12088678

The role of IFN-gamma in the outcome of chlamydial infection.

Martín E Rottenberg1, Antonio Gigliotti-Rothfuchs, Hans Wigzell.   

Abstract

Chlamydia are intracellular bacteria which infect many vertebrates, including humans. They cause a myriad of severe diseases, ranging from asymptomatic infection to pneumonia, blindness or infertility. IFN-gamma plays an important role in defense against acute infection and in the establishment of persistence. Chlamydia have evolved mechanisms to escape IFN-gamma functions. IFN-gamma-mediated effector mechanisms may involve effects on the metabolism of tryptophan or iron, on the inducible NO synthase (iNOS), on the secretion of chemokines and adhesion molecules or on the regulation of T-cell activities. IFN-gamma is secreted by the innate and the adaptive arms of the immune system. Within the former, Chlamydia-infected macrophages express IFN-gamma that in turn mediates resistance to infection. IFN-alpha/beta are pivotal for both IFN-gamma- and iNOS-mediated resistance to chlamydial infection in macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088678     DOI: 10.1016/s0952-7915(02)00361-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  59 in total

1.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Macrophage Polarization during Murine Lyme Borreliosis.

Authors:  Carrie E Lasky; Rachel M Olson; Charles R Brown
Journal:  Infect Immun       Date:  2015-04-13       Impact factor: 3.441

Review 3.  Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus.

Authors:  Georg Häcker; Susanne Kirschnek; Silke F Fischer
Journal:  Med Microbiol Immunol       Date:  2005-08-06       Impact factor: 3.402

4.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

5.  Hypoxia abrogates antichlamydial properties of IFN-γ in human fallopian tube cells in vitro and ex vivo.

Authors:  Anna Roth; Peter König; Ger van Zandbergen; Matthias Klinger; Thomas Hellwig-Bürgel; Walter Däubener; Michael K Bohlmann; Jan Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

6.  Effect of IL12A and IL12B polymorphisms on the risk of Chlamydia trachomatis-induced tubal factor infertility and disease severity.

Authors:  H Ohman; R Bailey; A Natividad; J Ragoussis; L-L Johnson; A Tiitinen; M Halttunen; J Paavonen; H-M Surcel
Journal:  Hum Reprod       Date:  2012-05-11       Impact factor: 6.918

7.  Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells.

Authors:  Christine Roshick; Heidi Wood; Harlan D Caldwell; Grant McClarty
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 8.  Acquisition of nutrients by Chlamydiae: unique challenges of living in an intracellular compartment.

Authors:  Hector Alex Saka; Raphael H Valdivia
Journal:  Curr Opin Microbiol       Date:  2009-12-16       Impact factor: 7.934

9.  Cytokine expression pattern in the genital tract of Chlamydia trachomatis positive infertile women - implication for T-cell responses.

Authors:  B S Reddy; S Rastogi; B Das; S Salhan; S Verma; A Mittal
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

10.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.